EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Determination of Olmesartan and Hydrochlorothiazide in Human Plasma by UPLC–MS/MS Method and Its Application to a Bioequivalence Study

Jie Shen, Lin Zhang iD, Jianbang Wu, Yan Zhou, Minhui Wang, Changmao Wang, LingLing Zhu, Yaqin Wang iD, Ping Wu, Xiaocui Xia, Wanyu Wang, Yamin Liu und 1 weitere

Biomedical Chromatography · 2026-01 · 40 (1)

DOI: 10.1002/bmc.70254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 28.11.2025. Verfasst von Jie Shen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Center of Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, People's Republic of China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Hydrochlorothiazide, Tetrazoles, Imidazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Special Foundation for Talents of Yijishan Hospital, "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple, sensitive and efficient ultra performance liquid chromatography–mass spectrometry (UPLC–MS/MS) method for simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma has been developed and validated. Using olmesartan‐d 4 and hydrochlorothiazide‐ 13 C‐d 2 as stable isotope‐labeled internal standard (SIL‐IS). Plasma samples were processed by protein precipitation. Separated on a ZORBAX Eclipse XDB‐Phenyl column (150 mm × 4.6 mm, 5 μm) using a gradient elution with mobile phases methanol and 5 mM ammonium acetate. Detected by electrospray ionization (ESI) in negative ion mode of multiple reaction monitoring (MRM), mass transition ion pairs were m/z 445.1 → 149.0 for olmesartan, m/z 295.9 → 204.9 for hydrochlorothiazide, m/z 449.1 → 149.1 for olmesartan‐d 4 , and m/z 301.0 → 272.0 for hydrochlorothiazide‐ 13 C‐d 2 . Linear ranges were 10–2000 ng/mL for olmesartan and 1.5–300 ng/mL for hydrochlorothiazide. Mean recoveries of olmesartan, hydrochlorothiazide, olmesartan‐d 4 , and hydrochlorothiazide‐ 13 C‐d 2 were 91.31%, 99.34%, 92.62%, and 98.61%, respectively. Our method was well validated in selectivity, carryover, lower limit of quantification (LLOQ), calibration curve, accuracy, precision, dilution effect, matrix effect (normal, hyperlipidemic, and hemolyzed matrices), stability, recovery, and IRS. It was successfully applied in a bioequivalence study of olmesartan medoxomil and hydrochlorothiazide tablets (20/12.5 mg) in healthy Chinese volunteers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryHydrochlorothiazideTetrazolesImidazolesHumansTherapeutic EquivalencyReproducibility of ResultsChromatography, High Pressure LiquidLinear ModelsMaleLimit of DetectionSensitivity and SpecificityAdultDrug StabilityLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

UPLC–MS/MShydrochlorothiazideolmesartanpharmacokineticplasms

Substanzen

HydrochlorothiazideTetrazolesolmesartanImidazoles

Autor:innen und Institutionen

  • Anhui Provincial Center of Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, People's Republic of China.
  • School of Pharmacy, Wannan Medical College, Wuhu, Anhui, People's Republic of China.
  • Anhui Wanbang Pharmaceutical Technology Co. Ltd, Hefei, China.

ORCID-Profile: Lin Zhang, Yaqin Wang, Yuanwei Jia

Förderung

  • Special Foundation for Talents of Yijishan Hospital
  • "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College

Zitieren

APA

Shen, J., Zhang, L., Wu, J., Zhou, Y., Wang, M., Wang, C., Zhu, L., Wang, Y., Wu, P., Xia, X., Wang, W., Liu, Y., & Jia, Y. (2026). Simultaneous Determination of Olmesartan and Hydrochlorothiazide in Human Plasma by UPLC–MS/MS Method and Its Application to a Bioequivalence Study. Biomedical Chromatography, 40(1). https://doi.org/10.1002/bmc.70254

Vancouver

Shen J, Zhang L, Wu J, Zhou Y, Wang M, Wang C, et al. Simultaneous Determination of Olmesartan and Hydrochlorothiazide in Human Plasma by UPLC–MS/MS Method and Its Application to a Bioequivalence Study. Biomedical Chromatography. 2026;40(1). doi:10.1002/bmc.70254

BibTeX
@article{Shen2026,
  author = {Shen, Jie and Zhang, Lin and Wu, Jianbang and Zhou, Yan and Wang, Minhui and Wang, Changmao and Zhu, LingLing and Wang, Yaqin and Wu, Ping and Xia, Xiaocui and Wang, Wanyu and Liu, Yamin and Jia, Yuanwei},
  title = {Simultaneous Determination of Olmesartan and Hydrochlorothiazide in Human Plasma by UPLC–MS/MS Method and Its Application to a Bioequivalence Study},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {1},
  doi = {10.1002/bmc.70254}
}
Kostenlos starten →